Medical supplies contracts in Germany

299 open tenders

CountryTenderValueClosesDays left

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Triptorelin, ATC L02AE04 for the period 01.09.2026 - 31.08.2028

DAK-Gesundheit, HamburgTED 491708-2026

€11 lot, 2 years

Wed 5 Jul12:00 in Berlin

615days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Abatacept, ATC L04AA24 for the period 01.09.2026 - 31.08.2028

DAK-Gesundheit, HamburgTED 493555-2026

€11 lot, 2 years

Wed 5 Jul12:00 in Berlin

615days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the Fifth Book of the German Social Code (SGB V) for the active substance natalizumab (only dosage form ILO), ATC L04AA23, for the period 01.09.2026 - 31.08.2028

DAK-Gesundheit, HamburgTED 491013-2026

€11 lot, 2 years

Wed 5 Jul12:00 in Berlin

615days

Open House Procedure for Collective Means

AOK Rheinland/Hamburg - Die Gesundheitskasse, DüsseldorfTED 372695-2026

value not stated1 lot, 2 years

Mon 31 Jul12:00 in Berlin

641days

Drug contracts with option to join

BARMER Beschaffung und Vergabe, WuppertalTED 640428-2026

value not stated3 lots

Tue 1 Aug12:00 in Berlin

642days

Conclusion of non-exclusive discount agreements pursuant to § 130a para. 8 of the German Social Code Book V (Open-House Model)

AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, EschbornTED 562187-2026

value not stated13 lots

Tue 1 Aug12:00 in Berlin

642days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance FAM OLIMEL (excluding electrolyte-free; 7, 6 %; KPG) + interchangeable FAM, ATC B05BA10 for the period 1.10.26-30.09.28

DAK-Gesundheit, HamburgTED 572069-2026

€11 lot, 2 years

Sat 5 Aug12:00 in Berlin

646days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Dapagliflozin, ATC A10BK01, for the period from 01.10.2026 to 30.09.2028

DAK-Gesundheit, HamburgTED 571195-2026

€11 lot, 2 years

Sat 5 Aug12:00 in Berlin

646days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the Fifth Book of the German Social Code (SGB V) for the active substance Rifaximin, ATC A07AA11, for the period 01.10.2026 - 30.09.2028

DAK-Gesundheit, HamburgTED 569831-2026

€11 lot, 2 years

Sat 5 Aug12:00 in Berlin

646days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Grass Pollen Extract (Timothy, Rye, etc.), ATC code V01AA02, for the period 01.10.2026 - 30.09.2028

DAK-Gesundheit, HamburgTED 571079-2026

€11 lot, 2 years

Sat 5 Aug12:00 in Berlin

646days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance FAM CERNEVIT (excluding KPG) and interchangeable FAM, ATC B05XC30, for the period 01.10.2026 - 30.09.2028

DAK-Gesundheit, HamburgTED 570900-2026

€11 lot, 2 years

Sat 5 Aug12:00 in Berlin

646days

Conclusion of a non-exclusive discount agreement under § 130a paragraph 8 of the German Social Security Code (SGB V) for the active substance Faricimab, ATC code S01LA09, for the period from 01.10.2026 to 30.09.2028

DAK-Gesundheit, HamburgTED 571028-2026

€11 lot, 2 years

Sat 5 Aug12:00 in Berlin

646days

Conclusion of non-exclusive discount agreements under § 130a Abs. 8 SGB V (Open-House Model)

AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, EschbornTED 681348-2026

value not stated7 lots

Fri 1 Sep12:00 in Berlin

673days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Iron (parenteral preparations), ATC B03AC07 for the period 01.11.25-31.10.27 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 606302-2025

€11 lot, 2 years

Tue 5 Sep12:00 in Berlin

677days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Iron (parenteral preparations), ATC B03AC02 for the period 01.11.25-31.10.27 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 607974-2025

€11 lot, 2 years

Tue 5 Sep12:00 in Berlin

677days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Iron (parenteral preparations), ATC B03AC01 for the period 01.11.25-31.10.27 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 603491-2025

€11 lot, 2 years

Tue 5 Sep12:00 in Berlin

677days

Open-House Contracts 2026-3

AOK Bremen/BremerhavenTED 619636-2026

value not stated37 lots

Sat 30 Sep23:59 in Berlin

702days

Conclusion of a non-exclusive rebate agreement pursuant to § 130a para. 8 SGB V for the active ingredient Glatiramer acetate (excluding pre-filled syringes), ATC L03AX13 for the period 01.12.2026 - 30.11.2028

DAK-Gesundheit, HamburgTED 713854-2026

€11 lot, 2 years

Thu 5 Oct12:00 in Berlin

707days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the Fifth Book of the German Social Code (SGB V) for the active substance Indacaterol + Glycopyrronium bromide, ATC R03AL04, for the period 01.12.2026 – 30.11.2028

DAK-Gesundheit, HamburgTED 712386-2026

€11 lot, 2 years

Thu 5 Oct12:00 in Berlin

707days

Conclusion of a non-exclusive rebate agreement pursuant to § 130a para. 8 SGB V for the active ingredient Botulinum toxin type A (excluding Onabotulinum), ATC M03AX21 for the period 01.12.2026 - 30.11.2028

DAK-Gesundheit, HamburgTED 712558-2026

€11 lot, 2 years

Thu 5 Oct12:00 in Berlin

707days

SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.